NSF International (NSF), an independent, not-for-profit organisation has announced its acquisition of UK based David Begg Associates (DBA).
Together, both NSF and DBA which provides training and auditing to the pharmaceutical and healthcare industries will provide technical services that will support the testing and training needs of pharmaceutical and biotech companies.
Key stakeholders will also benefit from this takeover, including manufacturers of pharmaceuticals, retailers and consumers.
Kevan P. Lawlor, President and CEO of NSF said: "This is an outstanding opportunity for both organizations to expand our global biotech services
“Combining DBA's extensive training and auditing experience with NSF's unsurpassed testing and certification expertise will position us as a leader in the global pharmaceutical industry."
Established in 1986, DBA has a global reputation in pharmaceutical quality management, regulatory compliance and training.
DBA’s strong position in the United Kingdom will give NSF an expanded presence in the European market, while providing additional training services to meet the requirements of clients worldwide.
NSF International plans to operate David Begg Associates as a standalone business within NSF UK Limited, LLC.
September 11 2007